Use of HIF alpha stabilizers for enhancing erythropoiesis

Details for Australian Patent Application No. 2004245071 (hide)

Owner FibroGen, Inc.

Inventors Lansetmo Parobok, Ingrid; Stephenson, Robert C.; Guenzler-Pukall, Volkmar; Molineaux, Christopher J.; Seeley, Todd W.; Neff, Thomas B.; Klaus, Stephen J.

Agent Spruson & Ferguson

Pub. Number AU-B-2004245071

PCT Pub. Number WO2004/108121

Priority 60/566,237 29.04.04 US; 60/566,488 29.04.04 US; 60/476,704 06.06.03 US; 60/569,797 10.05.04 US; 10/861,590 03.06.04 US

Filing date 4 June 2004

Wipo publication date 16 December 2004

Acceptance publication date 22 September 2011

International Classifications

A61K 31/00 (2006.01)

A61K 31/165 (2006.01) - having aromatic rings, e.g. colchicine, atenolol, progabide

A61K 31/395 (2006.01) - having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins

A61P 7/06 (2006.01) Drugs for disorders of the blood or the extracellular fluid

Event Publications

5 January 2006 PCT application entered the National Phase

  PCT publication WO2004/108121 Priority application(s): WO2004/108121

22 September 2011 Application Accepted

  Published as AU-B-2004245071

19 January 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004245072-Seating with comfort surface

2004245069-Intubation device